StockData
Bio Key International Inc logo

Bio Key International Inc (BKYI) stock

BKYINasdaqServices-Prepackaged SoftwareFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/3072% below fair value
$1.99+0.05 (+2.58%)

Close on Nov 18, 2026Market cap $2.86MP/E –Yield –

Bio Key International r&d expenses

Research and development expenses are spending on new products and technology.

Bio Key International's R&D Expenses for the twelve months ending Jun 30, 2026 was $2.64M, up 3.6% year over year. For fiscal 2025 it was $2.61M, up 3.9% from the year before. Over ten years it grew 5.3% a year on average. The highest annual figure on record is $3.25M in fiscal 2022.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.61M+3.9%
FY2024Dec 31, 2024$2.51M+4.9%
FY2023Dec 31, 2023$2.39M-26.4%
FY2022Dec 31, 2022$3.25M+38.1%
FY2021Dec 31, 2021$2.36M+68.6%
FY2020Dec 31, 2020$1.40M+4.9%
FY2019Dec 31, 2019$1.33M-5.9%
FY2018Dec 31, 2018$1.42M-14.7%
FY2017Dec 31, 2017$1.66M-17.4%
FY2016Dec 31, 2016$2.01M+29.1%
FY2015Dec 31, 2015$1.56M-4.3%
FY2014Dec 31, 2014$1.63M+21.0%
FY2013Dec 31, 2013$1.34M+41.9%
FY2012Dec 31, 2012$947.37K-15.2%
FY2011Dec 31, 2011$1.12M+5.7%
FY2010Dec 31, 2010$1.06M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$640.42K+0.7%
Q1 FY2026Mar 31, 2026$616.88K+3.5%
Q4 FY2025Dec 31, 2025$694.47K+5.2%
Q3 FY2025Sep 30, 2025$683.62K+4.8%
Q2 FY2025Jun 30, 2025$636.03K+7.6%
Q1 FY2025Mar 31, 2025$595.78K-1.9%
Q4 FY2024Dec 31, 2024$660.15K+7.0%
Q3 FY2024Sep 30, 2024$652.17K+23.1%
Q2 FY2024Jun 30, 2024$591.23K+5.9%
Q1 FY2024Mar 31, 2024$607.52K-12.0%
Q4 FY2023Dec 31, 2023$616.83K-26.0%
Q3 FY2023Sep 30, 2023$529.76K-36.1%
Q2 FY2023Jun 30, 2023$558.18K-28.8%
Q1 FY2023Mar 31, 2023$690.16K-14.3%
Q4 FY2022Dec 31, 2022$833.38K+2.9%
Q3 FY2022Sep 30, 2022$829.51K+35.4%
Q2 FY2022Jun 30, 2022$784.08K+59.7%
Q1 FY2022Mar 31, 2022$805.27K+82.3%
Q4 FY2021Dec 31, 2021$809.86K+97.6%
Q3 FY2021Sep 30, 2021$612.60K+85.0%
Q2 FY2021Jun 30, 2021$490.95K+54.1%
Q1 FY2021Mar 31, 2021$441.65K+31.1%
Q4 FY2020Dec 31, 2020$409.76K+15.0%
Q3 FY2020Sep 30, 2020$331.21K+10.4%
Q2 FY2020Jun 30, 2020$318.57K+5.8%
Q1 FY2020Mar 31, 2020$336.89K-10.0%
Q4 FY2019Dec 31, 2019$356.20K+6.6%
Q3 FY2019Sep 30, 2019$300.13K-23.3%
Q2 FY2019Jun 30, 2019$301.22K+1.2%
Q1 FY2019Mar 31, 2019$374.12K-4.6%
Q4 FY2018Dec 31, 2018$334.11K+1.1%
Q3 FY2018Sep 30, 2018$391.51K+1.2%
Q2 FY2018Jun 30, 2018$297.63K-33.7%
Q1 FY2018Mar 31, 2018$392.15K-20.5%
Q4 FY2017Dec 31, 2017$330.55K-22.1%
Q3 FY2017Sep 30, 2017$386.83K-26.8%
Q2 FY2017Jun 30, 2017$449.05K–
Q1 FY2017Mar 31, 2017$493.44K–
Q4 FY2016Dec 31, 2016$424.54K–
Q3 FY2016Sep 30, 2016$528.55K–

More Bio Key International figures

See a number that looks wrong?